Fluconazole and Para drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fluconazole (fluconazole) and Para (para - aminobenzoic acid (paba)). Common drug interactions include asthenia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Fluconazole and Para. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Fluconazole?

Fluconazole has active ingredients of fluconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 70,481 Fluconazole users. Check the latest studies of Fluconazole.

What is Para?

Para has active ingredients of para - aminobenzoic acid (paba). eHealthMe is studying from 2,194 Para users. Check the latest studies of Para.



On Jul, 16, 2026

23 people who take Fluconazole and Para together, and have interactions are studied.

Fluconazole and Para drug interactions.

What are the common drug interactions of Fluconazole and Para, by gender? *:

female:

  1. Asthenia (weakness)
  2. Vomiting
  3. Diarrhoea
  4. Electrolyte imbalance
  5. Genital ulceration (ulcers on sex organ)
  6. Hypotension (abnormally low blood pressure)
  7. Melaena (the passage of black, tarry stools)
  8. Oedema peripheral (superficial swelling)
  9. Oral herpes (viral infection of mouth)
  10. Swelling face

male:

  1. Anaemia (lack of blood)
  2. Electrocardiogram qt prolonged
  3. Neuropathy peripheral (surface nerve damage)
  4. Platelet count decreased
  5. Aortic valve disease
  6. Drug ineffective
  7. Endocarditis candida (an inflammation of the inner layer of the heart by infection by fungi)
  8. Mitral valve incompetence (inefficient heart valve)
  9. Nosocomial infection (infection from hospital)
  10. Pulmonary valve disease

What are the common drug interactions of Fluconazole and Para, by age (0-1 to 60+)? *:

0-1:

  1. Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
  2. Death
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Neuropathy peripheral (surface nerve damage)
  5. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)

2-9:

n/a

10-19:

n/a

20-29:

  1. Acute respiratory failure
  2. Arthralgia (joint pain)
  3. Asthenia (weakness)
  4. Cardiac failure
  5. Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
  6. Platelet count decreased
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Vomiting
  9. White blood cell count increased

30-39:

  1. Aortic valve disease
  2. Cardiac failure
  3. Drug ineffective
  4. Endocarditis candida (an inflammation of the inner layer of the heart by infection by fungi)
  5. Mitral valve incompetence (inefficient heart valve)
  6. Nosocomial infection (infection from hospital)
  7. Pulmonary valve disease
  8. Altered state of consciousness (altered state of mind)
  9. Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
  10. Confusional state

40-49:

  1. Anaemia (lack of blood)
  2. Asthenia (weakness)
  3. Cerebral toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii)
  4. Diarrhoea
  5. Electrolyte imbalance
  6. Genital ulceration (ulcers on sex organ)
  7. Hypotension (abnormally low blood pressure)
  8. Klebsiella sepsis (klebsiella causes a potentially fatal whole-body inflammation)
  9. Melaena (the passage of black, tarry stools)
  10. Oedema peripheral (superficial swelling)

50-59:

  1. Anaemia (lack of blood)
  2. Blood bicarbonate decreased
  3. Blood potassium decreased
  4. Blood sodium decreased
  5. Electrocardiogram qt prolonged
  6. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  7. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  8. Platelet count decreased

60+:

  1. Balance disorder
  2. Fall

What are the existing conditions these people have? *

  1. Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 11 people, 47.83%
  2. Hiv Infection: 6 people, 26.09%
  3. Bone Marrow Conditioning Regimen: 3 people, 13.04%
  4. Anaemia (lack of blood): 3 people, 13.04%
  5. Acquired Haemophilia (bleeding disorder disease): 3 people, 13.04%
  6. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 8.70%
  7. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 8.70%
  8. Pain: 2 people, 8.70%
  9. Oesophageal Candidiasis (fungal infection of oesophagus): 2 people, 8.70%
  10. Fever: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Fluconazole and Para?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fluconazole and Para:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fluconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Para:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluconazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Para and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluconazole and para - aminobenzoic acid (paba) (the active ingredients of Fluconazole and Para, respectively), and Fluconazole and Para (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: